// App-Quantinova.ai

[AB0524] : IMMUNOSUPPRESSIVE TREATMENT IN PATIENTS WITH PRIMARY SJOGREN SYNDROME (PSS)

Researchers

Presenter

  • G. Crespo Amaya

Principal Investigators

  • V. Martire

  • A. Nitsche

  • C. Asnal

  • C. Crow

  • P. Pucci

  • F. Caeiro

  • N. Benzaquen

  • J.P. Pirola

  • M. Colazo

  • O. Rillo

  • S. Papasidero

  • L. Marino

  • J. Demarchi

  • N. Tamborenea

  • L. Santiago

  • L. Raiti

  • C. Gobbi

  • E. Albiero

  • G. Salvatierra

  • A. Catalan Pellet

  • L. Carlevaris

  • G. Bennasar

  • M. Mamani

  • M. Mayer

  • F. Zazzetti

  • S. Velez

  • J.C. Barreira

Medical Centers

  • Rheumatology, IPRI, Santiago del Estero, Argentina

Locations

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Urology

Disease

  • Peripheral neuropathy

  • Autoimmune hepatitis

  • Glomerulonephritis

  • Chronic obstructive pulmonary disease

  • Sjogren's syndrome

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Oraprine

  • Methotrexate

  • HWA-486

  • Prednisone

  • Belimumab

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved